Gufic Biosciences Limited is engaged in the manufacture of pharmaceuticals, medicinal chemicals and botanical products.
Financial Results:
- Gufic BioSciences Ltd reported Revenues for Q2FY24 of ₹215.00 Crores up from ₹175.00 Crore year on year, a rise of 22.86%.
- Total Expenses for Q2FY24 of ₹184.00 Crores up from ₹149.00 Crores year on year, a rise of 23.49%.
- Consolidated Net Profit of ₹23.00 Crores up 15.0% from ₹20.00 Crores in the same quarter of the previous year.
- The Earnings per Share is ₹2.39, up 14.90% from ₹2.08 in the same quarter of the previous year.